Purchase Short-Term Access

Phase I Studies of Hypericin, the Active Compound in St. John's Wort, as an Antiretroviral Agent in HIV-Infected Adults: AIDS Clinical Trials Group Protocols 150 and 258
Roy M. Gulick, MD, MPH; Vincent McAuliffe, MD; Jeanne Holden-Wiltse, MPH; Clyde Crumpacker, MD; Leonard Liebes, PhD; Daniel S. Stein, MD; Patricia Meehan, PhD; Sheila Hussey, RN; Janet Forcht, RN; Fred T. Valentine, MD; for the AIDS Clinical Trials Group 150 and 258 Protocol Teams
Annals of Internal Medicine 1999;130:510-514. doi:10.7326/0003-4819-130-6-199903160-00015

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.